In a patient with a diagnosed thymoma and myasthenia gravis, should we still order acetylcholine‑receptor antibody testing or proceed directly to thymectomy?

Yes, Order Acetylcholine Receptor Antibodies Before Proceeding to Thymectomy

Before any surgical procedure, all patients suspected of having thymomas (even those without symptoms) should have their serum antiacetylcholine receptor antibody levels measured to determine whether they have myasthenia gravis to avoid respiratory failure during surgery 1.

Critical Pre-Surgical Testing Algorithm

Why Testing is Mandatory

Even with a confirmed diagnosis of both thymoma and myasthenia gravis, you must still order acetylcholine receptor (AChR) antibody testing before thymectomy for these specific reasons:

• Perioperative risk stratification: Positive AChR antibodies identify patients at high risk for respiratory failure during surgery 1
• Preoperative optimization: If antibodies are positive, patients require treatment by a neurologist experienced in myasthenia gravis before undergoing surgical resection 1
• Mortality prevention: Approximately 20% of thymoma patient mortality is related to myasthenia gravis complications 1

The Testing Sequence

1. Order AChR antibody testing immediately upon diagnosis of thymoma, regardless of clinical myasthenia gravis symptoms
2. Do not proceed directly to surgery without these results
3. If antibodies are positive: Refer to neurology for preoperative optimization with immunosuppressive therapy, plasmapheresis, or IVIG before thymectomy
4. If antibodies are negative but clinical MG present: Consider testing for muscle-specific kinase (MuSK) antibodies and LRP4 2

Important Clinical Context

The relationship between thymoma and myasthenia gravis creates unique diagnostic considerations:

• Approximately 30-50% of thymoma patients have myasthenia gravis 1
• Conversely, 15-20% of MG patients have thymoma 3
• Critical pitfall: Even patients without clinical MG symptoms can have positive AChR antibodies and develop postoperative complications 4
• Research shows 24% of thymoma patients without preoperative MG had positive AChR antibodies, and some developed MG postoperatively 4

Antibody Testing Sensitivity

• AChR antibodies are present in 87% of generalized MG patients 5
• In thymoma-associated MG, virtually all patients are AChR antibody positive 3
• Patients with thymoma tend to have higher antibody titers than MG patients without thymoma 5
• Titin antibodies provide 82.1% sensitivity for MG with thymoma and may add diagnostic value 6

Post-Testing Management

If AChR antibodies are positive, look for these symptoms requiring preoperative treatment:

• Drooping eyelids
• Double vision
• Drooling
• Difficulty climbing stairs
• Hoarseness
• Dyspnea 1

Thymectomy remains indicated regardless of antibody status, as it is recommended for all resectable thymomas and is always indicated in the presence of thymoma for MG patients 7, 2, 7, 2.

Long-term Monitoring Consideration

Patients with positive AChR antibodies preoperatively remain at risk for developing or worsening MG after thymectomy 8, 4. These patients require education about myasthenic crisis risks in specific situations such as stress or administration of certain drugs 8.